Literature DB >> 8329263

Alterations in pain threshold and psychomotor response associated with subanaesthetic concentrations of inhalation anaesthetics in humans.

K Tomi1, T Mashimo, C Tashiro, M Yagi, M Pak, S Nishimura, M Nishimura, I Yoshiya.   

Abstract

We studied the effects of six inhalation anaesthetics at subanaesthetic concentrations of 0.2 MAC on pain threshold and psychomotor function in six healthy volunteers. When compared with 100% oxygen inhalation, nitrous oxide and methyoxyflurane significantly increased pain threshold as measured by a radiant heat algometer, and prolonged the response time to auditory stimuli. In contrast, halothane, enflurane, isoflurane and sevoflurane produced prolongation of the response time to auditory stimuli but did not influence pain perception. The pain threshold with nitrous oxide remained significantly increased 30 min after its discontinuation, while the response time returned to the preinhalation value. We conclude that nitrous oxide and methoxyflurane possess both analgesic and hypnotic actions but halothane, enflurane, isoflurane and sevoflurane do not have an analgesic action at subanaesthetic concentrations, and the analgesic action of nitrous oxide persists after its elimination.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329263     DOI: 10.1093/bja/70.6.684

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

1.  General anesthetics activate a nociceptive ion channel to enhance pain and inflammation.

Authors:  José A Matta; Paul M Cornett; Rosa L Miyares; Ken Abe; Niaz Sahibzada; Gerard P Ahern
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-23       Impact factor: 11.205

2.  An equivalence study comparing nitrous oxide and oxygen with low-dose sevoflurane and oxygen as inhalation sedation agents in dentistry for adults.

Authors:  M Allen; S Thompson
Journal:  Br Dent J       Date:  2014-11       Impact factor: 1.626

Review 3.  Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.

Authors:  L Delgado-Herrera; R D Ostroff; S A Rogers
Journal:  CNS Drug Rev       Date:  2001

Review 4.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

5.  Isoflurane inhibits the tetrodotoxin-resistant voltage-gated sodium channel Nav1.8.

Authors:  Karl F Herold; Carla Nau; Wei Ouyang; Hugh C Hemmings
Journal:  Anesthesiology       Date:  2009-09       Impact factor: 7.892

6.  Discriminative stimulus effects of nitrous oxide in mice: comparison with volatile hydrocarbons and vapor anesthetics.

Authors:  Kellianne J Richardson; Keith L Shelton
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

7.  Physiological alteration, quality of anesthesia and economy of isoflurane in domestic chickens (Gallus domesticus).

Authors:  Parag Deori; Kushal Konwar Sarma; Parsha Jyoti Nath; Chandan Kumar Singh; Rita Nath
Journal:  Vet World       Date:  2017-05-08

Review 8.  The role of inhaled methoxyflurane in acute pain management.

Authors:  Keith M Porter; Anthony D Dayan; Sara Dickerson; Paul M Middleton
Journal:  Open Access Emerg Med       Date:  2018-10-18

9.  STOP!: a randomised, double-blind, placebo-controlled study of the efficacy and safety of methoxyflurane for the treatment of acute pain.

Authors:  Frank Coffey; John Wright; Stuart Hartshorn; Paul Hunt; Thomas Locker; Kazim Mirza; Patrick Dissmann
Journal:  Emerg Med J       Date:  2014-04-17       Impact factor: 2.740

10.  Methoxyflurane Analgesia in Adult Patients in the Emergency Department: A Subgroup Analysis of a Randomized, Double-blind, Placebo-controlled Study (STOP!).

Authors:  Frank Coffey; Patrick Dissmann; Kazim Mirza; Mark Lomax
Journal:  Adv Ther       Date:  2016-08-27       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.